Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Bonnie L. Bassler

At a glance: Bonnie L. Bassler is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Jan 8, 2026, reported a sale of $1.2M. On file: 0 purchase lines ($0) and 2 sale lines ($1.8M).

Disclosed holdings: about $1.6M of REGN stock: 1,703 shares reported on their latest Form 4 (filed Jan 8, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.8M

Bonnie L. Bassler's InsiderPrint

2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Bonnie L. Bassler: 2 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 1 sale
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Jan 8SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1,5001,703 held (−47%) $800.00 $1.2M +16.6%
Nov 24SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 7601,548 held (−33%) $750.00 $570K +24.3%
  • Sell

    Director Bonnie L Bassler sold $1.2M of REGN at $800.00 — cuts the stake by 47%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Bonnie L Bassler sold $570K of REGN at $750.00 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.

Follow Bonnie L. Bassler

Get one email when Bonnie L. Bassler files a new purchase or sale. Free.

At most one email a day about Bonnie L. Bassler, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.